The Senate Finance Committee yesterday voted to unanimously approve, as amended, the Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act. The legislation would require Medicare and Medicaid to provide beneficiaries better education, prevention, management and treatment options for pain and addiction; increase Medicare beneficiary awareness of non-opioid alternative treatments; increase treatment for substance use disorder; improve tracking of opioid prescriptions under Medicare Part D; expand and clarify Medicaid’s options for treating beneficiaries with substance use disorder; and improve data used to evaluate treatments for opioid use disorder. AHA yesterday voiced support for certain provisions in the bill.
 

Related News Articles

Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…